Rheumatoid Arthritis

Latest News
May 30th 2025

Anemia Linked With Higher Risk of All-Cause, CVD-Related Mortality in Rheumatoid Arthritis

May 24th 2025

Increased Incidence but Lower Mortality From RA Seen Over Last 3 Decades

May 16th 2025

Lung Ultrasound Can Accurately Detect ILD in Patients With RA

May 12th 2025

Differences in Clinical Trial Participation for Rheumatoid Arthritis, Lupus

May 8th 2025

Rheumatoid Arthritis Linked With Heightened Risk of Avoidable Hospitalizations

More News

The complex interplay between RA and metabolic health can have a significant impact on morbidity and mortality and thus deserves attention, authors of a new review argued. | Image credit: 9nong - stock.adobe.com
April 30th 2025

Assessing the Complex Interplay Between Metabolic Dysfunction and Rheumatoid Arthritis

Jared Kaltwasser
Many studies have examined how rheumatoid arthritis therapy affects the risk of metabolic comorbidities.
RA results from immune system disfunction, which differentiates the disease from osteoporosis, which results from wear-and-tear over time | image credit: doucefleur - stock.adobe.com
April 29th 2025

Personalized, Interdisciplinary Care Elevates RA Treatment

Kyle Munz
Jon Giles, MD, speaks to the power of personalized medicine and multidisciplinary care to enhance treatment for patients with rheumatoid arthritis (RA).
The investigators said wide-scale clinical trials will be required to collect and analyze patient-stratification data. At present, they said, achieving true precision medicine in RA remains something of a “moonshot” goal. | Image credit: MicroOne - stock.adobe.com
April 29th 2025

In Rheumatoid Arthritis, Precision Medicine Remains "Moonshot" Goal

Jared Kaltwasser
Efforts to more precisely select appropriate therapy for individual patients with rheumatoid arthritis have not yet yielded a clear-cut strategy, a new review finds.
Because serum analysis is already used to diagnose RA, track its progression, and understand response to therapy, the authors investigated whether reliable biomarkers could be found for refractory RA. | Image credit: angellodeco - stok.adobe.com
April 28th 2025

Serum Biomarkers for Refractory Active Rheumatoid Arthritis Remain Elusive

Jared Kaltwasser
New research suggests classical biomarkers cannot discriminate between refractory and non-refractory rheumatoid arthritis.
Elderly woman holding her hands | Image credit: Evrymmnt - stock.adobe.com
April 25th 2025

Clinical, Real-World Data Support Importance of Tocilizumab for RA

AJMC Contributor
Tocilizumab has emerged as a key treatment for rheumatoid arthritis, showing efficacy, safety, and potential cardiovascular benefits in recent studies.
ILD | Image Credit: PH alex aviles - stock.adobe.com
November 20th 2024

Study Highlights Key RA-ILD Risk Factors, Urges Early Screening

Brooke McCormick
This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Arthritis in hands - stockdevil - stock.adobe.com
July 20th 2024

Persistently Active Rheumatoid Arthritis Linked With Socioeconomic Factors

Lana Pine
Factors independently associated with persistently active RA included age, gender, previous or current smoking status, and social deprivation.
The review identified several challenges to quality rheumatoid arthritis treatment, along with potential interventions to improve care. | Image Credit: MicroOne - stock.adobe.com
July 18th 2024

Gaps in Rheumatoid Arthritis Care Quality Exist in North America

Rose McNulty
A literature review plus in-person visits helped identify barriers to quality rheumatoid arthritis care, as well as effective interventions to improve care quality.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo